This test is most useful if any of these apply to you.
You cannot see or taste arsenic in your drinking water, your rice bowl, or your morning coffee. Yet it enters bodies quietly through wells, food, and certain workplaces, and it leaves mostly through urine within days. That is what makes a 24-hour urine collection useful: it captures the total amount your kidneys cleared over a full day, giving a more stable read on recent exposure than a single spot sample.
This test answers a specific question: how much arsenic has your body handled in the last few days, and does the pattern suggest a toxic source or a benign one? The answer depends heavily on whether the lab separates the harmful inorganic forms from the harmless seafood-derived forms, because a high total number can look alarming when it is really just yesterday's tuna.
The assay quantifies arsenic that your kidneys excreted over 24 hours. About 40% of an ingested dose of inorganic arsenic appears in urine within 12 hours, and about 70% within 72 hours. With repeated exposure, urinary arsenic reaches a steady state within about 5 days, and roughly 60% of the daily dose comes out in urine at equilibrium in the classic controlled dosing studies, though longer-term biokinetic models suggest tissue equilibration can take months and daily fractional excretion may run higher at true steady state. Because arsenic clears from blood quickly and does not broadly accumulate in most soft tissues (though it does concentrate in keratin-rich tissues like hair and nails, and to a lesser extent bone), urine testing is the most common method for assessing ongoing or recent exposure.
There is a critical fork in interpretation. Total urinary arsenic includes both toxic inorganic species (called As-III and As-V) and their methylated byproducts (MMA and DMA), plus benign organic forms from seafood (arsenobetaine and arsenosugars). Speciation testing separates these. Without it, a dinner of sushi or shellfish can push your total urine arsenic into ranges that look toxic on a lab report but reflect no health concern at all.
This is the single most important thing to know before ordering the test. In one clinic series, patients paired before-and-after seafood-abstention testing had mean total urine arsenic of 291 µg/L before and only 9 µg/L after avoiding seafood for 48 to 72 hours. Some individuals had total urine arsenic between 272 and 907 µg/L that contained no detectable inorganic arsenic at all. The elevated number came entirely from harmless fish arsenic.
The trouble is that many labs report total arsenic and pair it with reference intervals designed for inorganic arsenic toxicity. Clinicians and patients read the number as alarming when it is not. If you cannot avoid seafood for two to three days before collecting, order the speciated test, which separately reports inorganic arsenic, MMA, DMA, and arsenobetaine.
In a prospective study of about 3,575 American Indian adults with low-to-moderate exposure, people in the highest quartile of urinary arsenic (compared to the lowest) had roughly 32% higher risk of new cardiovascular disease and about 65% higher risk of dying from cardiovascular disease. The pattern of arsenic metabolism also mattered: higher MMA percentage was generally linked to higher cardiovascular mortality.
The metabolism finding is worth pausing on. Your body converts inorganic arsenic into MMA and then into DMA, and DMA leaves the body faster. People who accumulate MMA appear to carry more cancer and cardiovascular risk. The picture is not entirely one-sided, though: in the same body of research, a higher DMA fraction (lower MMA%) has been paradoxically linked to higher diabetes risk. This is why a comprehensive read on arsenic includes both the exposure amount and the metabolism pattern, and why interpretation should not oversimplify to "more DMA is better."
In the same American Indian cohort, urinary arsenic tracked with higher long-term cancer mortality for specific sites. Comparing people at the 80th percentile of arsenic to those at the 20th, adjusted risk was about 56% higher for lung cancer, roughly three times higher for prostate cancer, and about 2.5 times higher for pancreatic cancer. The authors described a linear dose-response with no evidence of a threshold at low-to-moderate exposure, meaning risk climbed steadily rather than kicking in only at a certain level.
Kidney and liver cancer associations were smaller or not statistically significant in that cohort. Longer-window biomarkers such as toenail arsenic may better capture the years of exposure that drive slow-growing tumors.
Arsenic and kidneys interact in both directions. In a NHANES analysis of about 2,700 adolescents, urinary arsenic combined with other metals was linked to higher blood urea nitrogen, a marker of kidney workload. In a separate NHANES adult analysis, people in the highest quartile of urinary arsenic had about 29% higher odds of kidney damage, 49% higher odds of albuminuria (protein in urine), and 38% higher odds of hyperuricemia (elevated uric acid) compared to the lowest quartile.
The catch is that impaired kidneys handle arsenic differently, so the same exposure can produce different urine numbers in someone with reduced filtration. This is why any elevated result deserves interpretation alongside a kidney function panel rather than in isolation.
In an analysis of 8,104 U.S. adults, higher urinary inorganic arsenic was linked to non-alcoholic fatty liver disease with about 12% higher odds per level increase. The proposed mechanism involves inflammation signaling that promotes fat storage in liver cells. More recent work in the Multi-Ethnic Study of Atherosclerosis suggests the story may be more nuanced: arsenic methylation capacity, rather than total exposure alone, tracked with subclinical liver disease markers. Population-level associations do not prove causation for any individual, but the finding fits a broader pattern in which arsenic contributes to metabolic strain over years of low-grade exposure.
In pregnancy cohorts in Mexico, higher maternal urinary MMA was linked to lower newborn birth weight and shorter gestation. Higher maternal inorganic arsenic was linked to lower mean gestational age and shorter newborn length. These findings suggest early vascular and developmental effects on the fetus.
If you are pregnant or planning to become pregnant and drink from a private well, live near industrial arsenic sources, or eat rice-heavy diets, testing gives you a chance to identify and reduce exposure early.
| Population Studied | What Was Compared | What They Found |
|---|---|---|
| U.S. Strong Heart Study and MESA cohorts | Median urine arsenic across two U.S. cohorts | Roughly 5 to 6 µg/L, with community water arsenic explaining meaningful variation |
| Ethiopian community with groundwater exposure | Median urine arsenic in a chronic exposure setting | About 13.5 µg/L, with a wide range up to 126 µg/L |
| Malaysian adults, general population | Geometric mean urine arsenic in unexposed adults | About 48 µg/L, reflecting dietary sources including seafood and rice |
Source: Strong Heart Study and MESA cohort analyses; Ethiopian arsenicism study; Malaysian biomonitoring survey.
What this means for you: the same numeric result carries different meaning depending on where you live, what you eat, and what your water source is. What matters is comparing your baseline to itself over time, and setting that baseline against the exposure pathways in your life.
You may see two seemingly contradictory statements in the research: that urine arsenic is the best available exposure biomarker, and that a single urine arsenic value can be misleading. Both are true. Urine reflects real internal dose from all exposure routes, which is what makes it valuable. But that dose fluctuates from day to day with what you ate, whether you were dehydrated, and how well your kidneys are working. The way to hold both truths at once is to treat urine arsenic as a snapshot best interpreted with speciation, seafood context, and repeat sampling rather than as a one-shot verdict.
A single urine arsenic reading has limits. In one intensive repeated-sampling study of Chinese men over three months, reproducibility of individual arsenic values across spot samples was poor (intraclass correlations from 0.01 to 0.29). Other studies have reported moderate-to-good reproducibility (ICCs around 0.32 for first morning urine and higher over multi-year windows in some cohorts), so this range represents the more pessimistic end of the literature. The practical takeaway is unchanged: one measurement can be an imperfect guide to your true average, and value comes from testing repeatedly under standardized conditions.
A reasonable cadence: get a baseline 24-hour speciated arsenic test after abstaining from seafood for at least 48 to 72 hours. If you are making changes to your water source, diet, or supplement stack, retest in 3 to 6 months to see whether the changes moved the number. If levels are elevated, retest annually at minimum and more often if you are actively working to reduce exposure. Because the analyte reflects days-old exposure, retesting after a defined intervention gives fairly quick feedback on whether that intervention is working.
If your 24-hour urine arsenic comes back elevated, do not jump to chelation therapy or panic. The first step is to determine whether the elevation reflects toxic inorganic exposure or benign seafood arsenic. If your test measured only total arsenic, order a speciated test after 72 hours of strict seafood abstention. If speciation confirms elevated inorganic arsenic, MMA, or DMA that cannot be explained by seaweed or arsenosugars, then investigate the source.
The reason to test proactively is not to force a diagnosis; it is to catch an exposure source early enough to remove it before it causes lasting harm.
Evidence-backed interventions that affect your Arsenic level
Arsenic is best interpreted alongside these tests.
Arsenic is included in these pre-built panels.